Cargando…
The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
ERα positive breast cancer accounts for 70% of breast malignancies. Compared with ERα negative types, ERα positive breast cancer could be effective controlled by endocrine therapy. However, more than half of the patients will develop endocrine resistance, making it an important clinical issue for br...
Autores principales: | Zhu, Jian, Li, Xin, Su, Peng, Xue, Min, Zang, Yifeng, Ding, Yinlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605433/ https://www.ncbi.nlm.nih.gov/pubmed/32973333 http://dx.doi.org/10.1038/s41388-020-01464-z |
Ejemplares similares
-
The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression
por: Yuan, Lei, et al.
Publicado: (2022) -
RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020) -
Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression
por: Zhu, Jian, et al.
Publicado: (2016) -
Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187
por: Li, Xin, et al.
Publicado: (2022) -
Quality Control of ER Membrane Proteins by the RNF185/Membralin Ubiquitin Ligase Complex
por: van de Weijer, Michael L., et al.
Publicado: (2020)